When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TPTX - FDA grants fast-track designation for repotrectinib to Turning Point
Turning Point Therapeutics Inc.
The Food and Drug Administration (FDA) granted Turning Point Therapeutics (TPTX+2.0%) a third Fast-Track designation to its lead drug candidate, repotrectinib for treatment of patients with advanced solid tumors that have an NTRK gene fusion.
More news on: Turning Point Therapeutics, Inc., Healthcare stocks news, Stocks on the move,